Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Possible mechanisms of hypotension produced 70% alcoholic extract of Terminalia arjuna (L.) in anaesthetized dogs.

Nammi S, Gudavalli R, Babu BS, Lodagala DS, Boini KM.

BMC Complement Altern Med. 2003 Oct 16;3:5.

PMID:
14561229
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effect of Terminalia arjuna stem bark on antioxidant status in liver and kidney of alloxan diabetic rats.

Raghavan B, Kumari SK.

Indian J Physiol Pharmacol. 2006 Apr-Jun;50(2):133-42.

PMID:
17051732
[PubMed - indexed for MEDLINE]
3.

Effects of Terminalia arjuna bark extract on apoptosis of human hepatoma cell line HepG2.

Sivalokanathan S, Vijayababu MR, Balasubramanian MP.

World J Gastroenterol. 2006 Feb 21;12(7):1018-24.

PMID:
16534840
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The aqueous extract, not organic extracts, of Terminalia arjuna bark exerts cardiotonic effect on adult ventricular myocytes.

Oberoi L, Akiyama T, Lee KH, Liu SJ.

Phytomedicine. 2011 Feb 15;18(4):259-65. doi: 10.1016/j.phymed.2010.07.006.

PMID:
21315570
[PubMed - indexed for MEDLINE]
5.

Terminalia arjuna enhances baroreflex sensitivity and myocardial function in isoproterenol-induced chronic heart failure rats.

Parveen A, Babbar R, Agarwal S, Kotwani A, Fahim M.

J Cardiovasc Pharmacol Ther. 2012 Jun;17(2):199-207. doi: 10.1177/1074248411416816. Epub 2011 Aug 9.

PMID:
21828283
[PubMed - indexed for MEDLINE]
6.

Terminalia arjuna improves cardiovascular autonomic neuropathy in streptozotocin-induced diabetic rats.

Khaliq F, Parveen A, Singh S, Hussain ME, Fahim M.

Cardiovasc Toxicol. 2013 Mar;13(1):68-76. doi: 10.1007/s12012-012-9187-6.

PMID:
23001577
[PubMed - indexed for MEDLINE]
7.

Mechanistic clues in the cardioprotective effect of Terminalia arjuna bark extract in isoproterenol-induced chronic heart failure in rats.

Parveen A, Babbar R, Agarwal S, Kotwani A, Fahim M.

Cardiovasc Toxicol. 2011 Mar;11(1):48-57. doi: 10.1007/s12012-010-9099-2.

PMID:
21116736
[PubMed - indexed for MEDLINE]
8.

Arjunetin from Terminalia arjuna as an insect feeding-deterrent and growth inhibitor.

Singh DV, Gupta MM, Tripathi AK, Prajapati V, Kumar S.

Phytother Res. 2004 Feb;18(2):131-4.

PMID:
15022165
[PubMed - indexed for MEDLINE]
9.

Stem-bark of Terminalia arjuna attenuates human monocytic (THP-1) and aortic endothelial cell activation.

Kokkiripati PK, Kamsala RV, Bashyam L, Manthapuram N, Bitla P, Peddada V, Raghavendra AS, Tetali SD.

J Ethnopharmacol. 2013 Mar 27;146(2):456-64. doi: 10.1016/j.jep.2012.12.050. Epub 2013 Jan 24.

PMID:
23353898
[PubMed - indexed for MEDLINE]
10.

Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.).

Kumar S, Enjamoori R, Jaiswal A, Ray R, Seth S, Maulik SK.

J Pharm Pharmacol. 2009 Nov;61(11):1529-36. doi: 10.1211/jpp/61.11.0013.

PMID:
19903379
[PubMed - indexed for MEDLINE]
11.

Pentacyclic triterpenes from Terminalia arjuna show multiple benefits on aged and dry skin.

Farwick M, Köhler T, Schild J, Mentel M, Maczkiewitz U, Pagani V, Bonfigli A, Rigano L, Bureik D, Gauglitz GG.

Skin Pharmacol Physiol. 2014;27(2):71-81. doi: 10.1159/000351387. Epub 2013 Sep 5.

PMID:
24008587
[PubMed - indexed for MEDLINE]
12.

Terminalia arjuna protects mouse hearts against sodium fluoride-induced oxidative stress.

Sinha M, Manna P, Sil PC.

J Med Food. 2008 Dec;11(4):733-40. doi: 10.1089/jmf.2007.0130.

PMID:
19053867
[PubMed - indexed for MEDLINE]
13.

Improvement in myocardial function by Terminalia arjuna in streptozotocin-induced diabetic rats: possible mechanisms.

Khaliq F, Parveen A, Singh S, Gondal R, Hussain ME, Fahim M.

J Cardiovasc Pharmacol Ther. 2013 Sep;18(5):481-9. doi: 10.1177/1074248413488831. Epub 2013 May 14.

PMID:
23676315
[PubMed - indexed for MEDLINE]
14.

Antihyperglycemic activity and antioxidant role of Terminalia arjuna leaf in streptozotocin-induced diabetic rats.

Biswas M, Kar B, Bhattacharya S, Kumar RB, Ghosh AK, Haldar PK.

Pharm Biol. 2011 Apr;49(4):335-40. doi: 10.3109/13880209.2010.516755. Epub 2011 Feb 1.

PMID:
21281245
[PubMed - indexed for MEDLINE]
15.

Therapeutic potential of Terminalia arjuna in cardiovascular disorders.

Maulik SK, Talwar KK.

Am J Cardiovasc Drugs. 2012 Jun 1;12(3):157-63. doi: 10.2165/11598990-000000000-00000. Review.

PMID:
22583146
[PubMed - indexed for MEDLINE]
16.

Antigenotoxic properties of Terminalia arjuna bark extracts.

Scassellati-Sforzolini G, Villarini LM, Moretti LM, Marcarelli LM, Pasquini R, Fatigoni C, Kaur LS, Kumar S, Grover IS.

J Environ Pathol Toxicol Oncol. 1999;18(2):119-25.

PMID:
15281223
[PubMed - indexed for MEDLINE]
17.

Efficacy of Terminalia arjuna (Roxb.) on N-nitrosodiethylamine induced hepatocellular carcinoma in rats.

Sivalokanathan S, Ilayaraja M, Balasubramanian MP.

Indian J Exp Biol. 2005 Mar;43(3):264-7.

PMID:
15816414
[PubMed - indexed for MEDLINE]
18.

Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury.

Karthikeyan K, Bai BR, Gauthaman K, Sathish KS, Devaraj SN.

Life Sci. 2003 Oct 10;73(21):2727-39.

PMID:
13679240
[PubMed - indexed for MEDLINE]
19.

In vitro and in vivo Evaluation of CYP1A Interaction Potential of Terminalia Arjuna Bark.

Varghese A, Pandita N, Gaud RS.

Indian J Pharm Sci. 2014 Mar;76(2):138-47.

PMID:
24843187
[PubMed]
Free PMC Article
20.

Evaluation of phytoconstituents of Terminalia arjuna for wound healing activity in rats.

Chaudhari M, Mengi S.

Phytother Res. 2006 Sep;20(9):799-805.

PMID:
16835874
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk